Replies to post #151229 on Biotech Values

[DewDiligence]

NVS reports $85M of 4Q12 Lovenox sales, up from $34M in 3Q12:

http://www.novartis.com/newsroom/media-releases/en/2013/1672350.shtml

The $451M of Lovenox sales for the 2012 full year broke down into the four quarters as $176M, $156M, $34M, and $85M.

NVS had previously stated that the 3Q12 figure was artificially low due to one-time inventory adjustments.